Novel 1-Methyl-1H-pyrazole-5-carboxamide derivatives with potent anthelmintic activity
- Authors: Le, Thuy , Kundu, Abhijit , Ghoshal, Atanu , Nguyen, Nghi , Preston, Sarah , Jiao, Yaqing , Ruan, Banfeng , Xue, Lian , Huang, Fei , Keiser, Jennifer , Hofmann, Andreas , Chang, Bill , Garcia-Bustos, Jose , Wells, Timothy , Palmer, Michael , Jabbar, Abdul , Gasser, Robin , Baell, Jonathan
- Date: 2019
- Type: Text , Journal article
- Relation: Journal of Medicinal Chemistry Vol. 62, no. 7 (2019), p. 3367-3380
- Full Text: false
- Reviewed:
- Description: A phenotypic screen of two different libraries of small molecules against the motility and development of the parasitic nematode Haemonchus contortus led to the identification of two 1-methyl-1H-pyrazole-5-carboxamide derivatives. Medicinal chemistry optimization targeted modifications of the left-hand side, middle section, and right-hand side of the hybrid structure of these two hits to elucidate the structure-activity relationship (SAR). Initial SAR around these hits allowed for the iterative and directed assembly of a focused set of 30 analogues of their hybrid structure. Compounds 10, 17, 20, and 22 were identified as the most potent compounds, inhibiting the development of the fourth larval (L4) stage of H. contortus at sub-nanomolar potencies while displaying strong selectivity toward the parasite when tested in vitro against the human MCF10A cell line. In addition, compounds 9 and 27 showed promising activity against a panel of other parasitic nematodes, including hookworms and whipworms.
Structure-activity relationship studies of tolfenpyrad reveal subnanomolar inhibitors of haemonchus contortus development
- Authors: Le, Thuy , Kundu, Abhijit , Ghoshal, Atanu , Nguyen, Nghi , Preston, Sarah , Jiao, Yaqing , Ruan, Banfeng , Xue, Lian , Huang, Fei , Keiser, Jennifer , Hofmann, Andreas , Chang, Bill , Garcia-Bustos, Jose , Wells, Timothy , Palmer, Michael , Jabbar, Abdul , Gasser, Robin , Baell, Jonathan
- Date: 2019
- Type: Text , Journal article
- Relation: Journal of Medicinal Chemistry Vol. 62, no. 2 (2019), p. 1036-1053
- Full Text: false
- Reviewed:
- Description: Recently, we have discovered that the registered pesticide, tolfenpyrad, unexpectedly and potently inhibits the development of the L4 larval stage of the parasitic nematode Haemonchus contortus with an IC50 value of 0.03 mu M while displaying good selectivity, with an IC50 of 37.9 mu M for cytotoxicity. As a promising molecular template for medicinal chemistry optimization, we undertook anthelmintic structure-activity relationships for this chemical. Modifications of the left-hand side (LHS), right-hand side (RHS), and middle section of the scaffold were explored to produce a set of 57 analogues. Analogues 25, 29, and 33 were shown to be the most potent compounds of the series, with IC50 values at a subnanomolar level of potency against the chemotherapeutically relevant fourth larval (L4) stage of H. contortus. Selected compounds from the series also showed promising activity against a panel of other different parasitic nematodes, such as hookworms and whipworms.
Screening of the ‘Open Scaffolds’ collection from Compounds Australia identifies a new chemical entity with anthelmintic activities against different developmental stages of the barber's pole worm and other parasitic nematodes
- Authors: Preston, Sarah , Jiao, Yaqing , Baell, Jonathan , Keiser, Jennifer , Crawford, Simon , Koehler, Anson , Wang, Tao , Simpson, Moana , Kaplan, Ray , Cowley, Karla , Simpson, Kaylene , Hofmann, Andreas , Jabbar, Abdul , Gasser, Robin
- Date: 2017
- Type: Text , Journal article
- Relation: International Journal for Parasitology: Drugs and Drug Resistance Vol. 7, no. 3 (2017), p. 286-294
- Full Text:
- Reviewed:
- Description: The discovery and development of novel anthelmintic classes is essential to sustain the control of socioeconomically important parasitic worms of humans and animals. With the aim of offering novel, lead-like scaffolds for drug discovery, Compounds Australia released the ‘Open Scaffolds’ collection containing 33,999 compounds, with extensive information available on the physicochemical properties of these chemicals. In the present study, we screened 14,464 prioritised compounds from the ‘Open Scaffolds’ collection against the exsheathed third-stage larvae (xL3s) of Haemonchus contortus using recently developed whole-organism screening assays. We identified a hit compound, called SN00797439, which was shown to reproducibly reduce xL3 motility by ≥ 70%; this compound induced a characteristic, “coiled” xL3 phenotype (IC50 = 3.46–5.93 μM), inhibited motility of fourth-stage larvae (L4s; IC50 = 0.31–12.5 μM) and caused considerable cuticular damage to L4s in vitro. When tested on other parasitic nematodes in vitro, SN00797439 was shown to inhibit (IC50 = 3–50 μM) adults of Ancylostoma ceylanicum (hookworm) and first-stage larvae of Trichuris muris (whipworm) and eventually kill (>90%) these stages. Furthermore, this compound completely inhibited the motility of female and male adults of Brugia malayi (50–100 μM) as well as microfilariae of both B. malayi and Dirofilaria immitis (heartworm). Overall, these results show that SN00797439 acts against genetically (evolutionarily) distant parasitic nematodes i.e. H. contortus and A. ceylanicum [strongyloids] vs. B. malayi and D. immitis [filarioids] vs. T. muris [enoplid], and, thus, might offer a novel, lead-like scaffold for the development of a relatively broad-spectrum anthelmintic. Our future work will focus on assessing the activity of SN00797439 against other pathogens that cause neglected tropical diseases, optimising analogs with improved biological activities and characterising their targets. © 2017 The Authors